DNA methylation may partly explain psychotropic drug-induced metabolic side effects: results from a prospective 1-month observational study.

"Declarations Ethical approval and consent to participateThis study was carried out in accordance with the Declaration of Helsinki, the Swiss law, and local requirements. The study protocol was approved by the Ethics Committee of Vaud (CER-VD) with written informed consent from all subjects. Consent for publicationNot applicable. Competing interestsCBE received honoraria for conferences or teaching CME courses from Janssen-Cilag, Lundbeck, Otsuka, Sandoz, Servier, Sunovion, Takeda, Vifor-Pharma, and Zeller in the past 3 years. All authors declare that they have no conflicts of interest in relation to the content of this paper. Competing interests CBE received honoraria for conferences or teaching CME courses from Janssen-Cilag, Lundbeck, Otsuka, Sandoz, Servier, Sunovion, Takeda, Vifor-Pharma, and Zeller in the past 3 years. All authors declare that they have no conflicts of interest in relation to the content of this paper."

"Funding Open access funding provided by University of Lausanne. This work was funded in part by the Swiss National Science Foundation (CE and PC: 320030-120686, 324730-144064, and 320030-173211; CBE, PC and KJP: 320030-200602). The funding sources had no role in the writing of the manuscript or in the decision to submit it for publication."